Protalix Biotherapeutics, Inc. (PLX)

2.10 +0.03 (+1.45%) USD  |  NYAM  |  Jan 22, 16:00
2.08 -0.02 (-0.95%) After-Hours: 20:00
More

Protalix Biotherapeutics Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for PLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
OraSure Technologies, Inc. Upgrade
PAVmed, Inc. Upgrade
Denali Therapeutics, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade